Overview
Tatsuhiko Furukawa practices in Kagoshima, Japan. Furukawa is rated as an Advanced expert by MediFind in the treatment of Urea Cycle Disorders (UCD). Their top areas of expertise are Citrullinemia, Urea Cycle Disorders (UCD), Undifferentiated Pleomorphic Sarcoma, and Lung Cancer.
Their clinical research consists of co-authoring 58 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Urea Cycle Disorders (UCD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- CitrullinemiaFurukawa isAdvanced. Learn about Citrullinemia.
- Urea Cycle Disorders (UCD)Furukawa isAdvanced. Learn about Urea Cycle Disorders (UCD).
- Experienced
- Adult Soft Tissue SarcomaFurukawa isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AstrocytomaFurukawa isExperienced. Learn about Astrocytoma.
- GlioblastomaFurukawa isExperienced. Learn about Glioblastoma.
- GliomaFurukawa isExperienced. Learn about Glioma.
- Gliomatosis CerebriFurukawa isExperienced. Learn about Gliomatosis Cerebri.
- Lung AdenocarcinomaFurukawa isExperienced. Learn about Lung Adenocarcinoma.